MediciNova, Inc. (MNOV) vs Telomir Pharmaceuticals, Inc. Common Stock (TELO)
A side-by-side comparison of MediciNova, Inc. and Telomir Pharmaceuticals, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MNOV
MediciNova, Inc.
$1.69HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
TELO
Telomir Pharmaceuticals, Inc. Common Stock
$1.22HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — MNOV vs TELO
growth of $100 · dividends reinvested · last 3yMNOV +22.2% (+6.9%/yr)TELO -82.7% (-44.3%/yr)MNOV compounded faster over this window
Log scale — wide-divergence pair
MNOV TELO
MNOV vs TELO: by the numbers
- •TELO is the larger company ($84M vs $83M market cap).
- •Both run net losses; TELO's is the smaller (0.00% vs -1168.20% net margin).
Metrics side by side
Valuation
| Metric | MNOV | TELO |
|---|---|---|
| P/S ratio | 90.37 | N/A |
| P/B ratio | 2.23 | 16.65 |
Profitability
| Metric | MNOV | TELO |
|---|---|---|
| Gross margin | 7.58% | 0.00% |
| Operating margin | -3242.47% | 0.00% |
| Net margin | -1168.20% | 0.00% |
| ROE | -28.85% | -116.74% |
| ROIC | -31.62% | -120.93% |
Growth (annualized)
| Metric | MNOV | TELO |
|---|---|---|
| Revenue CAGR (5Y) | -25.46% | N/A |
| Total return CAGR (5Y) | -13.62% | N/A |
Go deeper
Dig into the metrics
MediciNova ROETelomir Pharmaceuticals, Inc. Common Stock ROEMediciNova operating marginTelomir Pharmaceuticals, Inc. Common Stock operating marginMediciNova revenue growthTelomir Pharmaceuticals, Inc. Common Stock revenue growthMediciNova free cash flowTelomir Pharmaceuticals, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.